Vaccine-associated "wild-type" measles

Pediatric Dermatology

Volumn 22, Issue 2, 2005, Pages 130-132

  Berggren, Kelle Liermann ^a,b   Tharp, Michael ^a   Boyer, Kenneth M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Dermatology Patient Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; VIRUS VACCINE;

ARTICLE; CASE REPORT; CHILDHOOD DISEASE; COMMON COLD; CONJUNCTIVITIS; COUGHING; DEVELOPING COUNTRY; DISEASE COURSE; FEVER; HUMAN; MALE; MEASLES; MEASLES VACCINATION; MICROBIAL ATTENUATION; MORBIDITY; MORTALITY; NASOPHARYNX; NOSE SECRETION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; VACCINATION; VIRUS DETECTION; WILD TYPE;

HUMANS; INFANT; MALE; MEASLES; MEASLES VACCINE; MORBILLIVIRUS; POLYMERASE CHAIN REACTION;

EID: 16344381321     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2005.22208.x     Document Type: Article

References (6)

1. Redd S, Markowitz E, Katz S. Measles vaccine. In: Plotkin S ed. Vaccines. Philadelphia: W.B. Saunders Co., 1999:222-266.
2. Goon P, Cohen B, Watkins R, et al. MMR vaccine in HIV-infected children - potential hazards? Vaccine 2001;19:3816-3819.
3. Davidkin I, Valle M, Peltola H. et al. Etiology of measles and rubella-like illnesses in measles, mumps and rubella vaccinated children. The J Infectious Dis 1998;178:1567-1570.
4. Jenkin G, Chibo D, Kelly H, et al. What is the cause of a rash after measles-mumps-rubella vaccination? Med J Australia 1999;171:194-195.
5. Patja A, Davidkin I, Kurki T, et al. Serious adverse events after measles-mumps-rubella vaccination during a 14-year prospective follow-up. The Pediatric Infectious Dis Journal 2000;19(12):1127-1134.
6. Kobune F, Funato M, Takahashi H, et al. Characterization of measles viruses isolated after measles vaccination. Vaccine 1995;13:370-372.